IL27 and inflammation: For instance, IL-30 gene therapy has been shown to efficiently inhibit autoimmune inflammation in the central nervous system (CNS) and eye (16), and lentiviral IL-27 gene delivery to the CNS inhibits neuroinflammation (17).